logo-loader
viewLexaria Bioscience Corp.

Lexaria Bioscience formulates enhanced DehydraTECH for more efficient cannabis delivery

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) CEO Chris Bunka tells Proactive Investors a new version of the Kelowna, British Columbia company’s DehydraTECH delivery platform has been developed.

Bunka says this new version provides significant improvements geared for use in solid oral dosage forms like capsules, tablets and pills for the pharmaceutical and supplement markets, as well as for cannabis.

Quick facts: Lexaria Bioscience Corp.

Price: 0.6 CAD

CSE:LXX
Market: CSE
Market Cap: $48.43 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp. named herein, including the promotion by the Company of Lexaria Bioscience Corp. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks hold steady; Lexaria rises on amended agreement...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, inched 0.2% higher at 122.9 points. Elsewhere, the OTCQX Cannabis index lost 0.2% to 489.3 points. Buds today are Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP), Curaleaf Holdings Inc...

on 22/1/20

2 min read